# Improving Cerebral Blood Flow and Cognition in Patients with Cerebral Small Vessel Disease. the ETLAS-2 Trial

Study · id `cardio:ct-nct05173896` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05173896](<https://clinicaltrials.gov/study/NCT05173896>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05173896

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT05173896. Randomized; quadruple masking; primary purpose prevention. Start 2022-05-31 (actual); primary completion 2024-09-23 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 2
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT05173896, source copy `cardio:ctgov-nct05173896-2024-12-09`, retrieved 2026-10-26)
- Started: 2022-05-31 (actual) (ClinicalTrials.gov record NCT05173896, source copy `cardio:ctgov-nct05173896-2024-12-09`, retrieved 2026-10-26)
- Primary completion: 2024-09-23 (actual) (ClinicalTrials.gov record NCT05173896, source copy `cardio:ctgov-nct05173896-2024-12-09`, retrieved 2026-10-26)
- Completion: 2029-12 (anticipated) (ClinicalTrials.gov record NCT05173896, source copy `cardio:ctgov-nct05173896-2024-12-09`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT05173896, source copy `cardio:ctgov-nct05173896-2024-12-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05173896-2024-12-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Improving Cerebral Blood Flow and Cognition in Patients with Cerebral Small Vessel Disease. the ETLAS-2 Trial
- Acronym: ETLAS2
- Condition: Cerebral Small Vessel Diseases
- Condition: Stroke, Ischemic
- Intervention (Drug): Tadalafil 20 MG
- Intervention (Drug): Placebo
- Lead sponsor: Christina Kruuse
- Lead sponsor class: OTHER
- Collaborator: Danish Research Centre for Magnetic Resonance
- Collaborator class: OTHER
- Collaborator: Bispebjerg Hospital
- Collaborator class: OTHER
- Collaborator: Copenhagen University Hospital, Rigshospitalet
- Collaborator class: OTHER
- Collaborator: University of Copenhagen
- Collaborator class: OTHER
- Collaborator: The Novo Nordic Foundation
- Collaborator class: OTHER
- Collaborator: Nordsjaellands Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Cerebral small vessel disease (`cardio:cerebral-small-vessel-disease`)
- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as a collaborator: Bispebjerg Hospital (`cardio:org-bispebjerg-hospital`)
- Registry lists this organization as a collaborator: Copenhagen University Hospital, Rigshospitalet (`cardio:org-copenhagen-university-hospital-rigshospitalet`)
- Registry lists this organization as a collaborator: University of Copenhagen (`cardio:org-university-of-copenhagen`)
- Registry lists this organization as a collaborator: Nordsjaellands Hospital (`cardio:org-nordsjaellands-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Tadalafil Treatment in Patients With Cerebral Small Vessel Disease: The ETLAS-2 Randomized Clinical Trial (`cardio:pubmed-40718899`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 254214123a07919f6fc575a664b646eb2d3c494f605b2b615d81b5d783490ffc
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
